Gene Logic, Inc. signed an agreement to sell its Genomics assets to Ocimum Biosolutions Ltd. for $10 million in cash. Under the terms of the agreement, Gene Logic retains full rights to use the existing information databases of its former Genomics business in building its drug repositioning and development business and will retain specified assets related to molecular diagnostics. Ocimum will assume certain liabilities associated with the Genomics assets and business. The sale is subject to cert...